Form 4 for TMO Thermo Fisher Scientific
Accepted 2023-08-29 00:00:00 ET · period of report 2023-08-25 · accession 0001127602-23-023364 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-08-29 | 2023-08-25+ | TMO | Williamson Stephen | SVP, CFO | F - Tax | $542.74 | -902.22 | 26.4K | -3% | -$489.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-28 | F | D | 178.90 | $545.19 | 26,194.89 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-28 | F | D | 110.24 | $545.19 | 26,084.65 | D | — | — | |
| 3 | Common | Common Stock | 2023-08-25 | F | D | 613.08 | $541.59 | 26,373.78 | D | — | — |